GoAI
Get started
Shigematsu Works Co., Ltd. logo

Shigematsu Works Co., Ltd.

7980.T

JPXHealthcareMedical - Instruments & Supplies

Open in GoAI

Latest quote

¥850

+¥2.00 · +0.24%

Aug 24, 11:22 AM JST

7980.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Established in 1917 and headquartered in Tokyo, Japan, Shigematsu Works Co., Ltd. is a prominent Japanese manufacturer and distributor of safety and protective gear. The company's extensive product portfolio features various personal protective equipment (PPE), including specialized clothing and gloves, eye protectors, and a comprehensive range of respirators such as reusable, disposable, powered air-purifying, supplied-air, self-contained breathing apparatus, and gas/chemical cartridge models. Additionally, they provide face shields, earmuffs, safety belts, stretchers, and oxygen meters. Beyond PPE, Shigematsu Works Co., Ltd. also manufactures and supplies instruments, chemicals, and materials essential for maintaining safety, promoting health, and mitigating disasters within both the plumbing and broader industrial sectors.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
Headquarters
JP
CEO
Nobuo Shigematsu
Listed since
Apr 2, 1963
Employees
399

Market position

Day range

Current ¥850

52-week range

Current ¥850

Open
¥848
Previous close
¥848
Volume
4.7K
0.17× average
Average volume
27.43K
Average daily volume
Market cap
6.04B JPY
Beta
0.08
Market reference 1
50-day average
¥818.5
+3.85% above average
200-day average
¥850.04
-0.00% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
7.67×
P/B (TTM)
0.62×
P/S (TTM)
0.38×
Dividend yield
1.76%

Profitability & efficiency

Gross margin
30.04%
Operating margin
7.51%
Net margin
4.94%

Financial health

Debt / equity
0.72×
Altman Z-score
1.99
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends34%23%12%2%Gross margin, FY2021: 30.47%Gross margin, FY2022: 31.12%Gross margin, FY2023: 30.21%Gross margin, FY2024: 30.44%Gross margin, FY2025: 29.56%Operating margin, FY2021: 5.08%Operating margin, FY2022: 7.50%Operating margin, FY2023: 6.04%Operating margin, FY2024: 7.58%Operating margin, FY2025: 6.76%Net margin, FY2021: 4.94%Net margin, FY2022: 5.81%Net margin, FY2023: 4.49%Net margin, FY2024: 5.53%Net margin, FY2025: 4.50%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 30.47%. Gross margin FY2022 31.12%. Gross margin FY2023 30.21%. Gross margin FY2024 30.44%. Gross margin FY2025 29.56%. Operating margin FY2021 5.08%. Operating margin FY2022 7.50%. Operating margin FY2023 6.04%. Operating margin FY2024 7.58%. Operating margin FY2025 6.76%. Net margin FY2021 4.94%. Net margin FY2022 5.81%. Net margin FY2023 4.49%. Net margin FY2024 5.53%. Net margin FY2025 4.50%.

Income trends

Revenue

15.59B JPY+10.49%

Operating income

1.05B JPY-1.36%

Net income

702.2M JPY-10.04%
Income trends across reported periods17.09B JPY11.09B JPY5.09B JPY−916.86M JPYRevenue, FY2021: 11.92B JPYRevenue, FY2022: 12.88B JPYRevenue, FY2023: 13B JPYRevenue, FY2024: 14.11B JPYRevenue, FY2025: 15.59B JPYOperating income, FY2021: 605.13M JPYOperating income, FY2022: 965.06M JPYOperating income, FY2023: 784.83M JPYOperating income, FY2024: 1.07B JPYOperating income, FY2025: 1.05B JPYNet income, FY2021: 589.11M JPYNet income, FY2022: 748.24M JPYNet income, FY2023: 584.08M JPYNet income, FY2024: 780.58M JPYNet income, FY2025: 702.2M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 11.92B JPY. Revenue FY2022 12.88B JPY. Revenue FY2023 13B JPY. Revenue FY2024 14.11B JPY. Revenue FY2025 15.59B JPY. Operating income FY2021 605.13M JPY. Operating income FY2022 965.06M JPY. Operating income FY2023 784.83M JPY. Operating income FY2024 1.07B JPY. Operating income FY2025 1.05B JPY. Net income FY2021 589.11M JPY. Net income FY2022 748.24M JPY. Net income FY2023 584.08M JPY. Net income FY2024 780.58M JPY. Net income FY2025 702.2M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue15.59B JPY14.11B JPY13B JPY12.88B JPY11.92B JPY
Cost of goods sold10.98B JPY9.82B JPY9.07B JPY8.87B JPY8.29B JPY
Gross profit4.61B JPY4.3B JPY3.93B JPY4.01B JPY3.63B JPY
Research and development—369.74M JPY372.09M JPY359.58M JPY390.17M JPY
Selling, general, and administrative3.56B JPY2.86B JPY2.77B JPY2.68B JPY2.64B JPY
Operating expenses3.56B JPY3.23B JPY3.14B JPY3.04B JPY3.03B JPY
Interest income1.84M JPY242K JPY62K JPY80K JPY107K JPY
Interest expense183.08M JPY40.89M JPY21.31M JPY18.81M JPY19.51M JPY
Depreciation and amortization919.04M JPY660.7M JPY526.59M JPY729.15M JPY643.05M JPY
Operating income1.05B JPY1.07B JPY784.83M JPY965.06M JPY605.13M JPY
Net income702.2M JPY780.58M JPY584.08M JPY748.24M JPY589.11M JPY

Company facts updated Aug 24, 2026.

7980.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥7,008

-0.04%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,799

+0.61%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,990

+0.38%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,205

+0.08%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,862

+1.01%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,392.5

+0.23%

Continue in GoAI

Research 7980.T

research.disclaimer